{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T11:03:14Z","timestamp":1792148594171,"version":"4.4.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2011,6,18]],"date-time":"2011-06-18T00:00:00Z","timestamp":1308355200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pathologe"],"published-print":{"date-parts":[[2011,7]]},"DOI":"10.1007\/s00292-011-1434-2","type":"journal-article","created":{"date-parts":[[2011,6,17]],"date-time":"2011-06-17T19:08:46Z","timestamp":1308337726000},"page":"330-335","source":"Crossref","is-referenced-by-count":6,"title":["Steatohepatitis bei der Chemotherapie kolorektaler Lebermetastasen (CASH)","Steatohepatitis after chemotherapy for colorectal liver metastases (CASH)"],"prefix":"10.1007","volume":"32","author":[{"given":"A.","family":"Tannapfel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Reinacher-Schick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Flott-Rahmel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,6,18]]},"reference":[{"key":"1434_CR1","doi-asserted-by":"crossref","first-page":"4983","DOI":"10.1200\/JCO.2006.05.8156","volume":"24","author":"Aloia","year":"2006","unstructured":"Aloia T, Sebagh M, Plasse M et al (2006) Liver histology and surgical outcomes after preoperative chemotherapy with fluorouracil plus oxaliplatin in colorectal cancer liver metastases. J Clin Oncol 24:4983\u20134990","journal-title":"J Clin Oncol"},{"key":"1434_CR2","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1016\/0016-5085(94)90235-6","volume":"107","author":"Bacon","year":"1994","unstructured":"Bacon BR, Farahvash MJ, Janney CG, Neuschwander-Tetri BA (1994) Nonalcoholic steatohepatitis: an expanded clinical entity. Gastroenterology 107:1103\u20131109","journal-title":"Gastroenterology"},{"key":"1434_CR3","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1200\/JCO.2010.32.6132","volume":"29","author":"Brouquet","year":"2011","unstructured":"Brouquet A, Abdalla EK, Kopetz S et al (2011) High survival rate after two-stage resection of advanced colorectal liver metastases: response-based selection and complete resection define outcome. J Clin Oncol 29:1083\u20131090","journal-title":"J Clin Oncol"},{"key":"1434_CR4","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1055\/s-2001-12925","volume":"21","author":"Brunt","year":"2001","unstructured":"Brunt EM (2001) Nonalcoholic steatohepatitis: definition and pathology. Semin Liver Dis 21:3\u201316","journal-title":"Semin Liver Dis"},{"key":"1434_CR5","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/S1089-3261(02)00002-8","volume":"6","author":"Brunt","year":"2002","unstructured":"Brunt EM (2002) Alcoholic and nonalcoholic steatohepatitis. Clin Liver Dis 6:399\u2013420","journal-title":"Clin Liver Dis"},{"key":"1434_CR6","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1053\/j.semdp.2006.04.002","volume":"22","author":"Brunt","year":"2005","unstructured":"Brunt EM (2005) Nonalcoholic steatohepatitis: pathologic features and differential diagnosis. Semin Diagn Pathol 22:330\u2013338","journal-title":"Semin Diagn Pathol"},{"key":"1434_CR7","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.hepres.2005.09.006","volume":"33","author":"Brunt","year":"2005","unstructured":"Brunt EM (2005) Pathology of nonalcoholic steatohepatitis. Hepatol Res 33:68\u201371","journal-title":"Hepatol Res"},{"key":"1434_CR8","doi-asserted-by":"crossref","first-page":"2467","DOI":"10.1111\/j.1572-0241.1999.01377.x","volume":"94","author":"Brunt","year":"1999","unstructured":"Brunt EM, Janney CG, Di Bisceglie AM et al (1999) Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions. Am J Gastroenterol 94:2467\u20132474","journal-title":"Am J Gastroenterol"},{"key":"1434_CR9","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1016\/j.humpath.2004.04.017","volume":"35","author":"Brunt","year":"2004","unstructured":"Brunt EM, Neuschwander-Tetri BA, Oliver D et al (2004) Nonalcoholic steatohepatitis: histologic features and clinical correlations with 30 blinded biopsy specimens. Hum Pathol 35:1070\u20131082","journal-title":"Hum Pathol"},{"key":"1434_CR10","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1097\/01.MP.0000042420.21088.C7","volume":"16","author":"Brunt","year":"2003","unstructured":"Brunt EM, Ramrakhiani S, Cordes BG et al (2003) Concurrence of histologic features of steatohepatitis with other forms of chronic liver disease. Mod Pathol 16:49\u201356","journal-title":"Mod Pathol"},{"key":"1434_CR11","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1053\/bega.2002.0326","volume":"16","author":"Brunt","year":"2002","unstructured":"Brunt EM, Tiniakos DG (2002) Pathology of steatohepatitis. Best Pract Res Clin Gastroenterol 16:691\u2013707","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"1434_CR12","first-page":"1475","volume":"10","author":"Brunt","year":"2005","unstructured":"Brunt EM, Tiniakos DG (2005) Pathological features of NASH. Front Biosci 10:1475\u20131484","journal-title":"Front Biosci"},{"key":"1434_CR13","first-page":"246","volume":"15","author":"Burt","year":"1998","unstructured":"Burt AD, Mutton A, Day CP (1998) Diagnosis and interpretation of steatosis and steatohepatitis. Semin Diagn Pathol 15:246\u2013258","journal-title":"Semin Diagn Pathol"},{"key":"1434_CR14","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1097\/00007890-200105150-00007","volume":"71","author":"Cheng","year":"2001","unstructured":"Cheng YF, Chen CL, Lai CY et al (2001) Assessment of donor fatty livers for liver transplantation. Transplantation 71:1221\u20131225","journal-title":"Transplantation"},{"key":"1434_CR15","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1053\/jhep.2002.30692","volume":"35","author":"Chitturi","year":"2002","unstructured":"Chitturi S, Abeygunasekera S, Farrell GC et al (2002) NASH and insulin resistance: Insulin hypersecretion and specific association with the insulin resistance syndrome. Hepatology 35:373\u2013379","journal-title":"Hepatology"},{"key":"1434_CR16","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1053\/j.gastro.2006.03.019","volume":"130","author":"Church","year":"2006","unstructured":"Church TS, Kuk JL, Ross R et al (2006) Association of cardiorespiratory fitness, body mass index, and waist circumference to nonalcoholic fatty liver disease. Gastroenterology 130:2023\u20132030","journal-title":"Gastroenterology"},{"key":"1434_CR17","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.jhep.2005.09.002","volume":"44","author":"Cortez-Pinto","year":"2006","unstructured":"Cortez-Pinto H, Moura MC de, Day CP (2006) Non-alcoholic steatohepatitis: from cell biology to clinical practice. J Hepatol 44:197\u2013208","journal-title":"J Hepatol"},{"key":"1434_CR18","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1016\/S0016-5085(98)70599-2","volume":"114","author":"Day","year":"1998","unstructured":"Day CP, James OF (1998) Steatohepatitis: a tale of two \u201ehits\u201c? Gastroenterology 114:842\u2013845","journal-title":"Gastroenterology"},{"key":"1434_CR19","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1055\/s-2002-23204","volume":"22","author":"DeLeve","year":"2002","unstructured":"DeLeve LD, Shulman HM, McDonald GB (2002) Toxic injury to hepatic sinusoids: sinusoidal obstruction syndrome (veno-occlusive disease). Semin Liver Dis 22:27\u201342","journal-title":"Semin Liver Dis"},{"key":"1434_CR20","first-page":"4539","volume":"13","author":"Duvnjak","year":"2007","unstructured":"Duvnjak M, Lerotic I, Barsic N et al (2007) Pathogenesis and management issues for non-alcoholic fatty liver disease. J Gastroenterol 13:4539\u20134550","journal-title":"J Gastroenterol"},{"key":"1434_CR21","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.cld.2007.02.011","volume":"11","author":"Edmison","year":"2007","unstructured":"Edmison J, McCullough AJ (2007) Pathogenesis of non-alcoholic steatohepatitis: human data. Clin Liver Dis 11:75\u2013104","journal-title":"Clin Liver Dis"},{"key":"1434_CR22","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1055\/s-2001-12926","volume":"21","author":"Falck-Ytter","year":"2001","unstructured":"Falck-Ytter Y, Younossi ZM, Marchesini G, McCullough AJ (2001) Clinical features and natural history of nonalcoholic steatosis syndromes. Semin Liver Dis 21:17\u201326","journal-title":"Semin Liver Dis"},{"key":"1434_CR23","doi-asserted-by":"crossref","first-page":"S99","DOI":"10.1002\/hep.20973","volume":"43","author":"Farrell","year":"2006","unstructured":"Farrell GC, Larter CZ (2006) Nonalcoholic fatty liver disease: from steatosis to cirrhosis. Hepatology 43:S99\u2013S112","journal-title":"Hepatology"},{"key":"1434_CR24","doi-asserted-by":"crossref","first-page":"5467","DOI":"10.1200\/JCO.2006.08.1828","volume":"24","author":"Gentilucci","year":"2006","unstructured":"Gentilucci UV, Santini D, Vincenzi B et al (2006) Chemotherapy-induced steatohepatitis in colorectal cancer patients. J Clin Oncol 24:5467\u20135468","journal-title":"J Clin Oncol"},{"key":"1434_CR25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/01.sla.0000193603.26265.c3","volume":"243","author":"Karoui","year":"2006","unstructured":"Karoui M, Penna C, Amin-Hashem M et al (2006) Influence of preoperative chemotherapy on the risk of major hepatectomy for colorectal liver metastases. Ann Surg 243:1\u20137","journal-title":"Ann Surg"},{"key":"1434_CR26","doi-asserted-by":"crossref","first-page":"2870","DOI":"10.1245\/s10434-010-1166-1","volume":"17","author":"Kishi","year":"2010","unstructured":"Kishi Y, Zorzi D, Contreras CM et al (2010) Extended preoperative chemotherapy does not improve pathologic response and increases postoperative liver insufficiency after hepatic resection for colorectal liver metastases. Ann Surg Oncol 17:2870\u20132876","journal-title":"Ann Surg Oncol"},{"key":"1434_CR27","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1002\/hep.20701","volume":"41","author":"Kleiner","year":"2005","unstructured":"Kleiner DE, Brunt EM, Van NM et al (2005) Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 41:1313\u20131321","journal-title":"Hepatology"},{"key":"1434_CR28","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.ejso.2008.12.013","volume":"35","author":"Klinger","year":"2009","unstructured":"Klinger M, Eipeldauer S, Hacker S et al (2009) Bevacizumab protects against sinusoidal obstruction syndrome and does not increase response rate in neoadjuvant XELOX\/FOLFOX therapy of colorectal cancer liver metastases. Eur J Surg Oncol 35:515\u2013520","journal-title":"Eur J Surg Oncol"},{"key":"1434_CR29","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/S0025-6196(24)00530-5","volume":"55","author":"Ludwig","year":"1980","unstructured":"Ludwig J, Viggiano TR, McGill DB, Oh BJ (1980) Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease. Mayo Clin Proc 55:434\u2013438","journal-title":"Mayo Clin Proc"},{"key":"1434_CR30","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1016\/S0016-5085(99)70506-8","volume":"116","author":"Matteoni","year":"1999","unstructured":"Matteoni CA, Younossi ZM, Gramlich T et al (1999) Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity. Gastroenterology 116:1413\u20131419","journal-title":"Gastroenterology"},{"key":"1434_CR31","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.2337\/diacare.27.8.2057","volume":"27","author":"Medina","year":"2004","unstructured":"Medina J, Fernandez-Salazar LI, Garcia-Buey L, Moreno-Otero R (2004) Approach to the pathogenesis and treatment of nonalcoholic steatohepatitis. Diabetes Care 27:2057\u20132066","journal-title":"Diabetes Care"},{"key":"1434_CR32","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1111\/j.1478-3231.2007.01483.x","volume":"27","author":"Mendez-Sanchez","year":"2007","unstructured":"Mendez-Sanchez N, Arrese M, Zamora-Valdes D, Uribe M (2007) Current concepts in the pathogenesis of nonalcoholic fatty liver disease. Liver Int 27:423\u2013433","journal-title":"Liver Int"},{"key":"1434_CR33","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1002\/ajh.20958","volume":"82","author":"Mori","year":"2007","unstructured":"Mori T, Aisa Y, Shimizu T et al (2007) Hepatic veno-occlusive disease after tranexamic acid administration in patients undergoing allogeneic hematopoietic stem cell transplantation. Am J Hematol 82:838\u2013839","journal-title":"Am J Hematol"},{"key":"1434_CR34","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1097\/SLA.0b013e31815774de","volume":"247","author":"Nakano","year":"2008","unstructured":"Nakano H, Oussoultzoglou E, Rosso E et al (2008) Sinusoidal injury increases morbidity after major hepatectomy in patients with colorectal liver metastases receiving preoperative chemotherapy. Ann Surg 247:118\u2013124","journal-title":"Ann Surg"},{"key":"1434_CR35","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1053\/jhep.2003.50193","volume":"37","author":"Neuschwander-Tetri","year":"2003","unstructured":"Neuschwander-Tetri BA, Caldwell SH (2003) Nonalcoholic steatohepatitis: summary of an AASLD Single Topic Conference. Hepatology 37:1202\u20131219","journal-title":"Hepatology"},{"key":"1434_CR36","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1016\/j.ejca.2007.07.017","volume":"43","author":"Nordlinger","year":"2007","unstructured":"Nordlinger B, Van CE, Rougier P et al (2007) Does chemotherapy prior to liver resection increase the potential for cure in patients with metastatic colorectal cancer? A report from the European Colorectal Metastases Treatment Group. Eur J Cancer 43:2037\u20132045","journal-title":"Eur J Cancer"},{"key":"1434_CR37","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1007\/s11605-007-0149-4","volume":"11","author":"Pawlik","year":"2007","unstructured":"Pawlik TM, Olino K, Gleisner AL et al (2007) Preoperative chemotherapy for colorectal liver metastases: impact on hepatic histology and postoperative outcome. J Gastrointest Surg 11:860\u2013868","journal-title":"J Gastrointest Surg"},{"key":"1434_CR38","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1093\/annonc\/mdh095","volume":"15","author":"Rubbia-Brandt","year":"2004","unstructured":"Rubbia-Brandt L, Audard V, Sartoretti P et al (2004) Severe hepatic sinusoidal obstruction associated with oxaliplatin-based chemotherapy in patients with metastatic colorectal cancer. Ann Oncol 15:460\u2013466","journal-title":"Ann Oncol"},{"key":"1434_CR39","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1111\/j.1365-2559.2010.03511.x","volume":"56","author":"Rubbia-Brandt","year":"2010","unstructured":"Rubbia-Brandt L, Lauwers GY, Wang H et al (2010) Sinusoidal obstruction syndrome and nodular regenerative hyperplasia are frequent oxaliplatin-associated liver lesions and partially prevented by bevacizumab in patients with hepatic colorectal metastasis. Histopathology 56:430\u2013439","journal-title":"Histopathology"},{"key":"1434_CR40","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1158\/1535-7163.MCT-10-1072","volume":"10","author":"Rubbia-Brandt","year":"2011","unstructured":"Rubbia-Brandt L, Tauzin S, Brezault C et al (2011) Gene expression profiling provides insights into pathways of oxaliplatin-related sinusoidal obstruction syndrome in humans. Mol Cancer Ther 10:687\u2013696","journal-title":"Mol Cancer Ther"},{"key":"1434_CR41","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.ejso.2006.11.022","volume":"34","author":"Schouten","year":"2008","unstructured":"Schouten Velden AP van der, Punt CJ et al (2008) Hepatic veno-occlusive disease after neoadjuvant treatment of colorectal liver metastases with oxaliplatin: a lesson of the month. Eur J Surg Oncol 34:353\u2013355","journal-title":"Eur J Surg Oncol"},{"key":"1434_CR42","doi-asserted-by":"crossref","first-page":"3283","DOI":"10.1016\/S0041-1345(01)02394-6","volume":"33","author":"Tannapfel","year":"2001","unstructured":"Tannapfel A, Geissler F, Witzigmann H et al (2001) Analysis of liver allograft rejection related genes using cDNA-microarrays in liver allograft specimen. Transplant Proc 33:3283\u20133284","journal-title":"Transplant Proc"},{"key":"1434_CR43","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1200\/JCO.2005.05.3074","volume":"24","author":"Vauthey","year":"2006","unstructured":"Vauthey JN, Pawlik TM, Ribero D et al (2006) Chemotherapy regimen predicts steatohepatitis and an increase in 90-day mortality after surgery for hepatic colorectal metastases. J Clin Oncol 24:2065\u20132072","journal-title":"J Clin Oncol"},{"key":"1434_CR44","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1093\/ajcn\/86.2.285","volume":"86","author":"Zivkovic","year":"2007","unstructured":"Zivkovic AM, German JB, Sanyal AJ (2007) Comparative review of diets for the metabolic syndrome: implications for nonalcoholic fatty liver disease. Am J Clin Nutr 86:285\u2013300","journal-title":"Am J Clin Nutr"},{"key":"1434_CR45","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1002\/bjs.5719","volume":"94","author":"Zorzi","year":"2007","unstructured":"Zorzi D, Laurent A, Pawlik TM et al (2007) Chemotherapy-associated hepatotoxicity and surgery for colorectal liver metastases. Br J Surg 94:274\u2013286","journal-title":"Br J Surg"}],"container-title":["Der Pathologe"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00292-011-1434-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00292-011-1434-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00292-011-1434-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,6]],"date-time":"2025-03-06T07:47:12Z","timestamp":1741247232000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00292-011-1434-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,6,18]]},"references-count":45,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2011,7]]}},"alternative-id":["1434"],"URL":"https:\/\/doi.org\/10.1007\/s00292-011-1434-2","relation":{},"ISSN":["0172-8113","1432-1963"],"issn-type":[{"value":"0172-8113","type":"print"},{"value":"1432-1963","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,6,18]]}}}